- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01818518
Neonatal Outcome by Reason for Delivery
Neonatal Outcome by Reason for Delivery - A Prospective, Observational Study
Study Overview
Status
Conditions
Detailed Description
This is a prospective, observational study that will use information from the medical records of mothers and their newborns. This study seeks to determine the rate of Composite Neonatal Morbidity for very preterm babies delivered secondary to preterm labor (PTL) vs. prelabor rupture of membranes (PROM). Composite neonatal morbidity is defined as ≥ 1 of the following: Respiratory Distress Syndrome (RDS) (oxygen requirement, clinical diagnosis, and consistent chest radiograph), bronchopulmonary dysplasia (BPD) (requirement for oxygen support at 28 days of life), severe intraventricular hemorrhage (IVH) (grades III or IV), periventricular leukomalacia (PVL), blood culture-proven sepsis, necrotizing enterocolitis (NEC), or perinatal death (stillbirth or death before neonatal hospital discharge.
Secondary Objectives: 1) Difference in mortality between the PTL and PROM groups, composite morbidity differences for other reasons for premature delivery, and individual morbidities including IVH, PVL, RDS, sepsis, seizures, BPD and NEC
Study Population: All babies from singleton pregnancies delivering in each of the involved hospitals who deliver at less than 32 weeks of gestation who are stillborn, who die in the delivery room and who are cared for in the Neonatal Intensive Care Unit (NICU) will be included.
Planned Sample Size: We plan a two year study and estimate based on historical data for the institutions to be included in the study, which should yield approximately 6000 babies less than (<) 32w0d gestation. For a 10% difference in composite morbidity (assuming 90% power and two-sided alpha=0.05) assuming a rate of 60% at least 661 patients are needed in each of the 3 groups (PTL, PROM, and other).
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Arizona
-
Mesa, Arizona, United States, 85210
- Banner Desert Medical Center
-
Phoenix, Arizona, United States, 85006
- Banner Good Samaritan Medical Center
-
Scottsdale, Arizona, United States, 85260
- Scottsdale Healthcare-Shea Medical Center
-
-
California
-
Laguna Hills, California, United States, 92653
- Saddleback Memorial Medical Center
-
San Jose, California, United States, 95008
- Good Samaritan Hospital
-
-
Colorado
-
Denver, Colorado, United States, 80218
- Presbyterian/St Luke's Hospital
-
-
Missouri
-
Kansas City, Missouri, United States, 64111
- Saint Luke's Hospital, Kansas City
-
Saint Louis, Missouri, United States, 63141
- Mercy Hospital of St. Louis
-
-
Texas
-
Fort Worth, Texas, United States, 76104
- Harris Methodist Hospital - Fort Worth
-
-
Washington
-
Seattle, Washington, United States, 98122-4307
- Swedish Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Delivery at participating hospitals at less than 32weeks of gestation based on best obstetrical dating
- Singleton pregnancy
Delivery where the baby is:
- Stillborn OR
- Born alive and:
- expires before it leaves the delivery room OR
- is cared for in the Neonatal Intensive Care Unit or an Intermediate Care Nursery
Exclusion Criteria:
- Patient less than 18 years of age
- Pregnancies that had previously been multiple gestations but where one or more fetuses had died after 12weeks of gestation
- Deliveries where the baby is born alive, does not expire in the delivery room but the baby does not get admitted to the NICU.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Preterm Labor
Group who goes into labor prior to 32 weeks of gestation
|
Prelabor rupture of membranes
Group who have prelabor rupture of membranes are those who break their bag of water prior to 32 weeks gestation in the absence of labor.
|
Premature birth before 32 weeks gestation
Premature birth before 32 weeks gestation not including PTL or PROM
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Composite Perinatal Morbidity
Time Frame: Infants from birth until discharge or until infant reaches 28 days of life.
|
The primary outcome is Composite Perinatal Morbidity.
Composite morbidity refers to the newborns born to the female participants enrolled in the study.
Composite Morbidity is defined as ≥ 1 of the following: respiratory distress syndrome (RDS) (oxygen requirement, clinical diagnosis, and consistent chest radiograph), bronchopulmonary dysplasia (BPD) (requirement for oxygen support at 28 days of life), severe intraventricular hemorrhage (IVH) (grades III or IV), periventricular leukomalacia (PVL), blood culture-proven sepsis present within 72 hours of birth, necrotising enterocolitis (NEC), or perinatal death (stillbirth or neonatal death prior to hospital discharge).
|
Infants from birth until discharge or until infant reaches 28 days of life.
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- OBX0022
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Preterm Delivery
-
Istanbul University - Cerrahpasa (IUC)CompletedPreterm Labor | Preterm Spontaneous Labor With Preterm Delivery | Preterm Labor With Preterm Delivery in Third TrimesterTurkey
-
University of Modena and Reggio EmiliaNot yet recruitingPreterm Labor With Preterm DeliveryItaly
-
Instituto de Investigacion Sanitaria La FeWithdrawn
-
Assistance Publique Hopitaux De MarseilleCompletedLow Risk of Preterm DeliveryFrance
-
University of Illinois at ChicagoTerminatedFocus: Prevent Preterm Delivery | Incidental Short Cervix at Mid-trimesterUnited States
-
Ain Shams UniversityRecruitingPreterm Labor With Preterm DeliveryEgypt
-
Ethem Unal, M.D., PhD, Associate Prof of Surgery...UnknownPreterm Birth | Preterm Labor | Preterm Labor Without Delivery | Side Effect of Drug | Preterm Labor With Preterm Delivery in Third Trimester | Calcium-Channel Blockers Toxicity
-
University Hospital, Strasbourg, FranceRecruitingPreterm Delivery | Threatened Preterm LaborFrance
-
Konya Meram State HospitalRecruitingPregnancy Preterm | Preterm Labor Without DeliveryTurkey
-
University of California, San FranciscoCompleted